Accreditation for Pharmacists
The American College of Clinical Pharmacy and American Society of Health-System Pharmacists are accredited by the Accreditation Council for Pharmacy Education as a providers of continuing pharmacy education.
These activities were presented as part of the 2022 Midyear Clinical Meeting. Learners who claimed ACPE credit for these activities as part of that meeting, should not claim ACPE credit again.
Target Audience
These recertification activities are intended for board certified pharmacists seeking to update their knowledge and skills in:
- ctDNA and minimal residual disease
- Bleeding disorders
Activity Overview
The Clinical Sessions Package is intended for board certified pharmacists in need of recertification credit and is designed based on the content outline developed by the Board of Pharmacy Specialties (BPS). Using a case-based approach, the activities provide high-level, interactive discussions on contemporary and emerging issues oncology.
The Oncology Clinical Sessions Recertification Package consists of 2 activities (see table below) and provides up to 4.0 contact hours of continuing pharmacy education and/or recertification credit.
These activities are part of the ASHP and ACCP professional development program for BCOP recertification approved by the BPS.
Recertification Credit*
Board certified pharmacists are eligible to receive up to 4.0 contact hours of recertification credit for completing this package. To earn recertification credit, learners must review the activity content and successfully complete the online assessments by the deadline. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed. You are allowed only one attempt to successfully complete this assessment.
Recertification credit is earned in the calendar year in which you pass the recertification assessment.
Learning Activity |
ACPE # |
Contact Hours |
Specialty |
Assessment Pass Point |
Taking a Deeper Dive: The Utilization of ctDNA and Minimal Residual Disease (MRD) to Assess Anticancer Therapeutic Response in Cancer |
0217-9999-22-070-H01-P |
2.0 ACPE |
BCOP |
|
The Alphabet Soup of Bleeding Disorders: Background and Treatment Updates in ITP, TTP, HUS, and DIC |
0217-9999-22-071-H01-P |
2.0 ACPE |
BCOP |
|
Total Contact Hours |
|
Methods and CE Requirements
Activities can be completed in any order. Each activity consists of video, PDFs and evaluations. Learners must review all content and complete the evaluations to receive continuing pharmacy education credit for each activity.
Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity.
System Technical Requirements
Learning activities are delivered via your Web browser and Acrobat PDF. For all activities, you should have a basic comfort level using a computer and navigating web sites.
View the minimum technical and system requirements for learning activities.
Development
These activities were developed by ACCP and ASHP.